Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors Meeting Abstract
| Authors: | Chi, S. N.; Bourdeaut, F.; Laetsch, T. W.; Fouladi, M.; Macy, M. E.; Makin, G. W. J.; Shukla, N. N.; Wetmore, C.; Margol, A. S.; Casanova, M.; Kilburn, L. B.; Yi, J.; Hargrave, D. R.; McCowage, G. B.; Pinto, N. R.; Ebb, D.; Robinson, G. W.; Sierra, L.; Merchant, M.; Nysom, K. |
| Abstract Title: | Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 530s |
| Language: | English |
| ACCESSION: | WOS:000560368300243 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.10525 |
| Notes: | Meeting Abstract: 10525 -- Source: Wos |
